Concerns on perioperative anaemia management in the FIT trial

Affiliations

¹ Department of Internal Medicine V (Hematology and Oncology), Austria.
² Department of Internal Medicine II (Infectious Disease, Immunology Rheumatology, Pneumology), Austria; Christian Doppler Laboratory for Iron Metabolism and Anemia Research, Medical University of Innsbruck, Austria. Electronic address: guenter.weiss@i-med.ac.at.

Comment

Verena Petzer et al. Lancet Haematol. 2023 Jul.

. 2023 Jul;10(7):e485.

doi: 10.1016/S2352-3026(23)00132-1.

¹ Department of Internal Medicine V (Hematology and Oncology), Austria.
² Department of Internal Medicine II (Infectious Disease, Immunology Rheumatology, Pneumology), Austria; Christian Doppler Laboratory for Iron Metabolism and Anemia Research, Medical University of Innsbruck, Austria. Electronic address: guenter.weiss@i-med.ac.at.

No abstract available

Conflict of interest statement

GW received lecture honoraria from Vifor.

Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial.
Talboom K, Borstlap WAA, Roodbeen SX, Bruns ERJ, Buskens CJ, Hompes R, Tytgat KMAJ, Tuynman JB, Consten ECJ, Heuff G, Kuiper T, van Geloven AAW, Veldhuis GJ, van der Hoeven JAB, Gerhards MF, Sietses C, Spinelli A, van de Ven AWH, van der Zaag ES, Westerterp M, van Westreenen HL, Dijkgraaf ML, Juffermans NP, Bemelman WA; FIT collaborative group. Talboom K, et al. Lancet Haematol. 2023 Apr;10(4):e250-e260. doi: 10.1016/S2352-3026(22)00402-1. Epub 2023 Feb 27. Lancet Haematol. 2023. PMID: 36863386 Clinical Trial.